$35m is to be paid upfront, with a further $40m depending on future milestones.
Apica Cardiovascular, an Ireland-based medical device company, has been acquired by US-based medical device company Thoratec. The deal is worth a total $75m, with Thoratec paying $35m upfront and $40m once future clinical and sales milestones have been met.
Both companies focus on patients with heart failure. Apica’s technology allows surgeons to open and close the apex of a beating heart, to deliver therapeutic devices into the inner chambers of the heart in a minimally invasive manner.
The spin-out, created…
